• Return to Headlines

Shares of Novavax Inc Rise to a New 52-Week High

By Shiri Gupta

Shares of Novavax Inc (NASDAQ:NVAX) traded today at $8.25, breaking its 52-week high. So far today approximately 1.4 million shares have been exchanged, as compared to an average 30-day volume of 798,000 shares.

Over the past year, Novavax Inc has traded in a range of $0.02 to $8.25 and is now at $8.25, 41,150% above that low. The 200-day and 50-day moving averages have moved 8.13% higher and 0.47% lower over the past week, respectively.

Novavax Inc (NASDAQ:NVAX) is currently priced 52.4% above its average consensus analyst price target of $3.93. Novavax Inc shares have support at the 50-day moving average (MA) of $5.03 and additional support at the 200-day MA of $1.89.

Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary Novavax, Inc., together with its subsidiary, Novavax AB, a late-stage biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases.

SmarTrend is monitoring the recent change of momentum in Novavax Inc. Please refer to our Company Overview for the results of our proprietary technical indicators that have been scanning shares of Novavax Inc in search of a potential trend change.

Keywords: 52 week high/lows novavax inc

Ticker(s): NVAX